Efficacy and safety of single- and repeated-selurampanel dosing for 2 weeks in patients with chronic subjective tinnitus: Results of a randomized, double-blind, placebo-controlled, cross-over, proof-of-concept phase IIa study

Progress in Brain Research - Tinnitus - An Interdisciplinary Approach Towards Individualized Treatment: From Heterogeneity to Personalized Medicine ◽

10.1016/bs.pbr.2020.12.004 ◽

2021 ◽

pp. 423-440

Author(s):

Klaus Kucher ◽

Donald Johns ◽

Frank Wagner ◽

Khalid Abd-Elaziz ◽

Caroline Derne ◽

...

Keyword(s):

Proof Of Concept ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Subjective Tinnitus

Download Full-text

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(14)70730-3 ◽

2014 ◽

Vol 14 (8) ◽

pp. 706-715 ◽

Cited By ~ 118

Author(s):

Jenny G Low ◽

Cynthia Sung ◽

Limin Wijaya ◽

Yuan Wei ◽

Abhay P S Rathore ◽

...

Keyword(s):

Dengue Fever ◽

Proof Of Concept ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 1B

Download Full-text

A Randomized, Double-blind, Placebo-controlled Proof-of-Concept Trial to Evaluate the Efficacy and Safety of Non-racemic Amisulpride (SEP-4199) for the Treatment of Bipolar I Depression

Journal of Affective Disorders ◽

10.1016/j.jad.2021.09.109 ◽

2021 ◽

Author(s):

Antony Loebel ◽

Kenneth S. Koblan ◽

Joyce Tsai ◽

Ling Deng ◽

Maurizio Fava ◽

...

Keyword(s):

Proof Of Concept ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

OP0047 A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Study to Evaluate the Efficacy and Safety of Sirukumab in Patients with Active Lupus Nephritis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.3974 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 78.2-78 ◽

Cited By ~ 7

Author(s):

R. van Vollenhoven ◽

C. Aranow ◽

B. Rovin ◽

C. Wagner ◽

B. Zhou ◽

...

Keyword(s):

Lupus Nephritis ◽

Phase 2 ◽

Proof Of Concept ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Concept Study ◽

Active Lupus Nephritis ◽

Active Lupus

Download Full-text

Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

Journal of Pain Research ◽

10.2147/jpr.s274562 ◽

2020 ◽

Vol Volume 13 ◽

pp. 3355-3369

Author(s):

Lesley M. Arnold ◽

Mary Beth Blauwet ◽

Katherine Tracy ◽

Na Cai ◽

Mark Walzer ◽

...

Keyword(s):

Controlled Trial ◽

Proof Of Concept ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus

BMC Ear Nose and Throat Disorders ◽

10.1186/1472-6815-11-1 ◽

2011 ◽

Vol 11 (1) ◽

Cited By ~ 27

Author(s):

Markus Suckfüll ◽

Michael Althaus ◽

Barbara Ellers-Lenz ◽

Alexander Gebauer ◽

Roman Görtelmeyer ◽

...

Keyword(s):

Clinical Trial ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Subjective Tinnitus

Download Full-text

Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-202646 ◽

2013 ◽

Vol 73 (2) ◽

pp. 349-356 ◽

Cited By ~ 219

Author(s):

Iain B McInnes ◽

Joachim Sieper ◽

Jürgen Braun ◽

Paul Emery ◽

Désirée van der Heijde ◽

...

Keyword(s):

Monoclonal Antibody ◽

Psoriatic Arthritis ◽

Phase Ii ◽

Proof Of Concept ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Interleukin 17A

Download Full-text

Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study

Diabetes Care ◽

10.2337/dc14-1044 ◽

2014 ◽

Vol 37 (12) ◽

pp. 3253-3261 ◽

Cited By ~ 43

Author(s):

Aaron Vinik ◽

Julio Rosenstock ◽

Uma Sharma ◽

Karen Feins ◽

Ching Hsu ◽

...

Keyword(s):

Neuropathic Pain ◽

Phase 2 ◽

Proof Of Concept ◽

Efficacy And Safety ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Active Comparator ◽

Phase 2 Study

Download Full-text

Mo1540 THE EFFICACY AND SAFETY OF GCWB104 (FLOS LONICERA EXTRACT) IN FUNCTIONAL DYSPEPSIA: A SINGLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Gastroenterology ◽

10.1016/s0016-5085(20)32906-1 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-887-S-888

Author(s):

Nayoung Kim ◽

Yonghoon Choi ◽

Dong Ho Lee

Keyword(s):

Functional Dyspepsia ◽

Controlled Study ◽

Efficacy And Safety ◽

Single Center ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Yearbook of Neurology and Neurosurgery ◽

10.1016/s0513-5117(09)79049-0 ◽

2009 ◽

Vol 2009 ◽

pp. 99-103

Author(s):

O. Kantarci

Keyword(s):

Multiple Sclerosis ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Efficacy and safety of liraglutide 3.0 mg in adult overweight and obese weight loss responders without diabetes: results of the randomised, double-blind, placebo-controlled 56-week SCALE Obesity and Prediabetes trial

Diabetologie und Stoffwechsel ◽

10.1055/s-0035-1556574 ◽

2015 ◽

Vol 10 (04) ◽

Author(s):

P O'Neil ◽

K Fujioka ◽

R Violante Ortiz ◽

B Claudius ◽

C Jensen ◽

...

Keyword(s):

Weight Loss ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text